Sohail Dhanji

University of California San Diego

Papers

4

Total Citations

64

H-Index

4

About

Sohail Dhanji is a rising surgical oncologist whose research is reshaping the management of urologic malignancies, particularly renal cell carcinoma (RCC) and upper tract urothelial carcinoma (UTUC). His work centers on optimizing surgical decision-making, comparing partial versus radical nephrectomy for complex renal masses, and refining techniques like bladder cuff excision during nephroureterectomy. Dhanji’s contributions are anchored in large-scale collaborative registry analyses, including the ROSULA and ROBUUST 2.0 groups, which provide real-world evidence on oncological outcomes and complications. His 2023 review on RCC highlights partial nephrectomy as the gold standard for localized disease, while his 2024 study on racial disparities in UTUC survival underscores a commitment to health equity. With papers accumulating citations rapidly—his most cited work on complex renal masses has already garnered 36 citations—Dhanji is building a reputation for rigorous, impactful research that directly informs clinical practice. His work not only advances surgical techniques but also addresses critical gaps in outcomes for diverse patient populations, making him a key voice in the next generation of urologic oncology.

Research Focus

Key Achievements

4
H-Index
4
Papers
64
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group
36 citations · 2023
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 69
🏛 Institutions: University of California San Diego

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago